Inventor · disambiguated record
Congxin Liang
Also filed as: LIANG CONGXIN · LIANG CONGXIN CHRIS
43 granted patents·20 pending applications·722 citations·filing 1999–2025
98Inventor score
Files withSUGEN INC20LIANG CONGXIN13HANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO LTD7SCRIPPS RESEARCH INST5XCOVERY HOLDING CO LLC5
Top patents by PatentIndex Score
63 records- 0197US6573293B2Pyrrole substituted 2-indolinone protein kinase inhibitorsSUGEN INC·Filed 2001·Granted Jun 3, 2003·174 cites·29 claims
- 0296US8524709B2Kinase inhibitor compoundsLIANG CONGXIN·Filed 2012·Granted Sep 3, 2013·42 cites·17 claims
- 0396US7125905B2Pyrrole substituted 2-indolinone protein kinase inhibitorsSUGEN INC·Filed 2005·Granted Oct 24, 2006·59 cites·2 claims
- 0495US6777417B23-(4,5,6,7-tetrahydroindol-2-ylmethylidiene-2-indolinone derivatives as kinase inhibitorsSUGEN INC·Filed 2002·Granted Aug 17, 2004·56 cites·4 claims
- 0594US6653308B23-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitorsSUGEN INC·Filed 2002·Granted Nov 25, 2003·75 cites·40 claims
- 0694US6610688B24-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitorsSUGEN INC·Filed 2000·Granted Aug 26, 2003·74 cites·22 claims
- 0793US7572924B2Pyrrole substituted 2-indolinone protein kinase inhibitorsSUGEN INC·Filed 2006·Granted Aug 11, 2009·25 cites·3 claims
- 0890US11053224B2Polymorphic forms of kinase inhibitor compound, pharmaceutical composition containing same, preparation method therefor and use thereofEQUINOX SCIENCES LLC·Filed 2017·Granted Jul 6, 2021·7 cites·53 claims
- 0990US7186832B2Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitorsSUGEN INC·Filed 2004·Granted Mar 6, 2007·32 cites·4 claims
- 1090US6689806B1Indolinone compounds as kinase inhibitorsSUGEN INC·Filed 2000·Granted Feb 10, 2004·29 cites·19 claims
- 1189US8586582B2PI3K/mTOR kinase inhibitorsLIANG CONGXIN·Filed 2009·Granted Nov 19, 2013·14 cites·16 claims
- 1289US8569296B2PI3K (delta) selective inhibitorsLIANG CONGXIN·Filed 2010·Granted Oct 29, 2013·11 cites·7 claims
- 1388US8039470B2Kinase inhibitor compoundsTYROGENEX INC·Filed 2010·Granted Oct 18, 2011·12 cites·5 claims
- 1486US10738060B2JAK1 selective inhibitors and uses thereofTLL PHARMACEUTICAL LLC·Filed 2017·Granted Aug 11, 2020·4 cites·12 claims
- 1585US7683057B2Kinase inhibitor compoundsTYROGENEX INC·Filed 2007·Granted Mar 23, 2010·8 cites·22 claims
- 1684US6599902B25-aralkysufonyl-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitorsSUGEN INC·Filed 2002·Granted Jul 29, 2003·21 cites·23 claims
- 1782US8513221B2PI3K isoform selective inhibitorsLIANG CONGXIN·Filed 2009·Granted Aug 20, 2013·5 cites·4 claims
- 1882US7256189B23-(4-amidopyrrol-2-ylmethylidene)-2-indolinone der derivatives as protein kinase inhibitorsUPJOHN CO·Filed 2006·Granted Aug 14, 2007·4 cites·2 claims
- 1981US8697866B2Substituted pyridazine carboxamide compounds as kinase inhibitor compoundsLIANG CONGXIN·Filed 2009·Granted Apr 15, 2014·3 cites·6 claims
- 2079US7179910B23-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitorsAGOURON PHARMA·Filed 2003·Granted Feb 20, 2007·10 cites·13 claims
- 2179US6642232B23-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as kinase inhibitorsSUGEN INC·Filed 2002·Granted Nov 4, 2003·13 cites·25 claims
- 2278USRE49834EJak1 selective inhibitors and uses thereofHANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO LTD·Filed 2017·Granted Feb 13, 2024·1 cites·22 claims
- 2377US12297206B2Method for synthesizing furoimidazopyridine compound, polymorphic substance and polymorphic substance of saltHANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO LTD·Filed 2020·Granted May 13, 2025·1 cites·3 claims
- 2477US7157460B2Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitorsSUGEN INC·Filed 2004·Granted Jan 2, 2007·8 cites·4 claims
- 2575US8198276B2Kinase inhibitor compoundsLIANG CONGXIN·Filed 2008·Granted Jun 12, 2012·2 cites·6 claims
- 2674US12195476B2Synthesis method of furoimidazopyridine compound, crystal form of furoimidazopyridine compound, and crystal form of salt thereofHANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO LTD·Filed 2020·Granted Jan 14, 2025·1 cites·27 claims
- 2774US8551995B2Kinase inhibitor compoundsLIANG CONGXIN·Filed 2008·Granted Oct 8, 2013·1 cites·6 claims
- 2874US6908930B24-substituted 7-AZA-indolin-2-ones and their use as protein kinase inhibitorsSUGEN INC·Filed 2003·Granted Jun 21, 2005·6 cites·12 claims
- 2972US8501763B2Inhibitors of focal adhesion kinaseLIANG CONGXIN·Filed 2008·Granted Aug 6, 2013·1 cites·16 claims
- 3072US7157577B25-sulfonamido-substituted indolinone compounds as protein kinase inhibitorsSUGEN INC·Filed 2004·Granted Jan 2, 2007·6 cites·2 claims
- 3171US12209080B2Polymorphic forms of kinase inhibitor compound, pharmaceutical composition containing same, preparation method therefor and use thereofEQUINOX SCIENCES LLC·Filed 2021·Granted Jan 28, 2025·0 cites·45 claims
- 3271US9126947B2Substituted pyridazine carboxamide compoundsLIANG CONGXIN·Filed 2011·Granted Sep 8, 2015·1 cites·5 claims
- 3370US7629339B2Alkoxy indolinone based protein kinase inhibitorsSCRIPPS RESEARCH INST·Filed 2006·Granted Dec 8, 2009·1 cites·31 claims
- 3469US10851084B2Piperazine derivatives as TRPML modulatorsCALYGENE BIOTECHNOLOGY INC·Filed 2017·Granted Dec 1, 2020·1 cites·18 claims
- 3569US6855730B23-methylidenyl-2-indolinone modulators of protein kinaseSUGEN INC·Filed 2003·Granted Feb 15, 2005·1 cites·15 claims
- 3668US9242958B2Substituted pyridazine carboxamide compounds as kinase inhibitor compoundsLIANG CONGXIN·Filed 2011·Granted Jan 26, 2016·1 cites·7 claims
- 3768US8912178B2mTOR selective kinase inhibitorsLIANG CONGXIN·Filed 2011·Granted Dec 16, 2014·1 cites·11 claims
- 3866US9296724B2Substituted pyridazinecarboxamides as kinase inhibitorsXCOVERY HOLDING CO LLC·Filed 2014·Granted Mar 29, 2016·1 cites·12 claims
- 3964US6531502B13-Methylidenyl-2-indolinone modulators of protein kinaseSUGEN INC·Filed 1999·Granted Mar 11, 2003·10 cites·17 claims
- 4064US2025188063A1Polymorphic forms of kinase inhibitor compound, pharmaceutical composition containing same, preparation method therefor and use thereofEQUINOX SCIENCES LLC·Filed 2025·Application pending·0 cites
- 4163US7582756B23-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitorsSUGEN INC·Filed 2007·Granted Sep 1, 2009·0 cites·3 claims
- 4260US2025263420A1Method for synthesizing furoimidazopyridine compound, polymorphic substance and polymorphic substance of saltHANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 4357US2025032465A1Methods of treating cns disordersHANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 4453US2011224212A1Kinase inhibitor compoundsTYROGENEX INC·Filed 2011·Application pending·0 cites
- 4553US2025206742A1Nlrp3 inflammasome inhibitorsHANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 4653US2004063773A1Pyrrole substituted 2-indolinone protein kinase inhibitorsSUGEN INC & PHARMACIA & UPJOHN·Filed 2003·Application pending·0 cites
- 4753US2008269212A1Amino acid derivatives of indolinone based protein kinase inhibitorsSCRIPPS RESEARCH INST·Filed 2006·Application pending·0 cites
- 4852US2006287381A1Enhanced indolinone based protein kinase inhibitorsSCRIPPS RESEARCH INST·Filed 2006·Application pending·0 cites
- 4952US2010267719A1Enhanced Indolinone Based Protein Kinase InhibitorsSCRIPPS RESEARCH INST·Filed 2006·Application pending·0 cites
- 5052US2009068718A1Amino acid derivatives of indolinone based protein kinase inhibitorsLIANG CONGXIN·Filed 2006·Application pending·0 cites
Showing the top 50 of 63 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Congxin Liang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →